{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T03:21:13Z","timestamp":1785468073496,"version":"3.56.0"},"reference-count":157,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,2,19]],"date-time":"2016-02-19T00:00:00Z","timestamp":1455840000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Neurol"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1038\/nrneurol.2016.14","type":"journal-article","created":{"date-parts":[[2016,2,19]],"date-time":"2016-02-19T10:08:24Z","timestamp":1455876504000},"page":"175-185","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":119,"title":["Parkinsonism, movement disorders and genetics in frontotemporal dementia"],"prefix":"10.1038","volume":"12","author":[{"given":"Jos\u00e9 Fidel","family":"Baizabal-Carvallo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Jankovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,19]]},"reference":[{"key":"BFnrneurol201614_CR1","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1212\/01.wnl.0000334277.16896.fa","volume":"71","author":"L Mercy","year":"2008","unstructured":"Mercy, L., Hodges, J. R., Dawson, K., Barker, R. A. & Brayne, C. Incidence of early-onset dementias in Cambridgeshire, United Kingdom. Neurology 71, 1496\u20131499 (2008).","journal-title":"Neurology"},{"key":"BFnrneurol201614_CR2","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1055\/s-0033-1359316","volume":"33","author":"DC Perry","year":"2013","unstructured":"Perry, D. C. & Miller, B. L. Frontotemporal dementia. Semin. Neurol. 33, 336\u2013341 (2013).","journal-title":"Semin. Neurol."},{"key":"BFnrneurol201614_CR3","doi-asserted-by":"publisher","first-page":"841","DOI":"10.2165\/11640070-000000000-00000","volume":"26","author":"RE Seltman","year":"2012","unstructured":"Seltman, R. E. & Matthews, B. R. Frontotemporal lobar degeneration: epidemiology, pathology, diagnosis and management. CNS Drugs 26, 841\u2013870 (2012).","journal-title":"CNS Drugs"},{"key":"BFnrneurol201614_CR4","doi-asserted-by":"publisher","first-page":"3474","DOI":"10.1093\/brain\/awt266","volume":"136","author":"M Teichmann","year":"2013","unstructured":"Teichmann, M.  et al. Deciphering logopenic primary progressive aphasia: a clinical, imaging and biomarker investigation. Brain 136, 3474\u20133488 (2013).","journal-title":"Brain"},{"key":"BFnrneurol201614_CR5","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s12031-011-9568-5","volume":"45","author":"S Fujioka","year":"2011","unstructured":"Fujioka, S. & Wszolek, Z. K. Clinical aspects of familial forms of frontotemporal dementia associated with parkinsonism. J. Mol. Neurosci. 45, 359\u2013365 (2011).","journal-title":"J. Mol. Neurosci."},{"key":"BFnrneurol201614_CR6","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.parkreldis.2014.06.004","volume":"20","author":"J Siuda","year":"2014","unstructured":"Siuda, J., Fujioka, S. & Wszolek, Z. K. Parkinsonian syndrome in familial frontotemporal dementia. Parkinsonism Relat. Disord. 20, 957\u2013964 (2014).","journal-title":"Parkinsonism Relat. Disord."},{"key":"BFnrneurol201614_CR7","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1212\/WNL.51.6.1546","volume":"51","author":"D Neary","year":"1998","unstructured":"Neary, D.  et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 51, 1546\u20131554 (1998).","journal-title":"Neurology"},{"key":"BFnrneurol201614_CR8","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1093\/brain\/awr179","volume":"134","author":"K Rascovsky","year":"2011","unstructured":"Rascovsky, K.  et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 134, 2456\u20132477 (2011).","journal-title":"Brain"},{"key":"BFnrneurol201614_CR9","doi-asserted-by":"crossref","unstructured":"The Lund and Manchester groups. Clinical and neuropathological criteria for frontotemporal dementia. J. Neurol. Neurosurg. Psychiatry 57, 416\u2013418 (1994).","DOI":"10.1136\/jnnp.57.4.416"},{"key":"BFnrneurol201614_CR10","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1111\/j.1468-1331.2007.01773.x","volume":"14","author":"J Diehl-Schmid","year":"2007","unstructured":"Diehl-Schmid, J.  et al. Extrapyramidal signs, primitive reflexes and incontinence in fronto-temporal dementia. Eur. J. Neurol. 14, 860\u2013864 (2007).","journal-title":"Eur. J. Neurol."},{"key":"BFnrneurol201614_CR11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.neulet.2007.05.049","volume":"422","author":"A Padovani","year":"2007","unstructured":"Padovani, A., Agosti, C., Premi, E., Bellelli, G. & Borroni, B. Extrapyramidal symptoms in frontotemporal dementia: prevalence and clinical correlations. Neurosci. Lett. 422, 39\u201342 (2007).","journal-title":"Neurosci. Lett."},{"key":"BFnrneurol201614_CR12","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1093\/brain\/awq123","volume":"133","author":"H Ling","year":"2010","unstructured":"Ling, H.  et al. Does corticobasal degeneration exist? A clinicopathological re-evaluation. Brain 133, 2045\u20132057 (2010).","journal-title":"Brain"},{"key":"BFnrneurol201614_CR13","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1002\/mds.25509","volume":"28","author":"M Stamelou","year":"2013","unstructured":"Stamelou, M., Quinn, N. P. & Bhatia, K. P. 'Atypical' atypical parkinsonism: new genetic conditions presenting with features of progressive supranuclear palsy, corticobasal degeneration, or multiple system atrophy \u2014 a diagnostic guide. Mov. Disord. 28, 1184\u20131199 (2013).","journal-title":"Mov. Disord."},{"key":"BFnrneurol201614_CR14","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1002\/mds.26054","volume":"29","author":"G Respondek","year":"2014","unstructured":"Respondek, G.  et al. The phenotypic spectrum of progressive supranuclear palsy: a retrospective multicenter study of 100 definite cases. Mov. Disord. 29, 1758\u20131766 (2014).","journal-title":"Mov. Disord."},{"key":"BFnrneurol201614_CR15","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1212\/WNL.0b013e31827f0fd1","volume":"80","author":"MJ Armstrong","year":"2013","unstructured":"Armstrong, M. J.  et al. Criteria for the diagnosis of corticobasal degeneration. Neurology 80, 496\u2013503 (2013).","journal-title":"Neurology"},{"key":"BFnrneurol201614_CR16","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1136\/jnnp-2011-300875","volume":"83","author":"R Mathew","year":"2012","unstructured":"Mathew, R., Bak, T. H. & Hodges, J. R. Diagnostic criteria for corticobasal syndrome: a comparative study. J. Neurol. Neurosurg. Psychiatry 83, 405\u2013410 (2012).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BFnrneurol201614_CR17","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1097\/WCO.0b013e32833be924","volume":"23","author":"DW Dickson","year":"2010","unstructured":"Dickson, D. W., Ahmed, Z., Algom, A. A., Tsuboi, Y. & Josephs, K. A. Neuropathology of variants of progressive supranuclear palsy. Curr. Opin. Neurol. 23, 394\u2013400 (2010).","journal-title":"Curr. Opin. Neurol."},{"key":"BFnrneurol201614_CR18","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1093\/brain\/awh488","volume":"128","author":"DR Williams","year":"2005","unstructured":"Williams, D. R.  et al. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism. Brain 128, 1247\u20131258 (2005).","journal-title":"Brain"},{"key":"BFnrneurol201614_CR19","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1002\/ana.410410606","volume":"41","author":"NL Foster","year":"1997","unstructured":"Foster, N. L.  et al. Frontotemporal dementia and parkinsonism linked to chromosome 17: a consensus conference. Ann. Neurol. 41, 706\u2013715 (1997).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol201614_CR20","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/31508","volume":"393","author":"M Hutton","year":"1998","unstructured":"Hutton, M.  et al. Association of missense and 5\u2032-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393, 702\u2013705 (1998).","journal-title":"Nature"},{"key":"BFnrneurol201614_CR21","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/nature05016","volume":"442","author":"M Baker","year":"2006","unstructured":"Baker, M.  et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 442, 916\u2013919 (2006).","journal-title":"Nature"},{"key":"BFnrneurol201614_CR22","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/j.1468-1331.2008.02513.x","volume":"16","author":"AC Ludolph","year":"2009","unstructured":"Ludolph, A. C.  et al. Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options. Eur. J. Neurol. 16, 297\u2013309 (2009).","journal-title":"Eur. J. Neurol."},{"key":"BFnrneurol201614_CR23","first-page":"161","volume":"67","author":"CE Yu","year":"2010","unstructured":"Yu, C. E.  et al. The spectrum of mutations in progranulin: a collaborative study screening 545 cases of neurodegeneration. Arch. Neurol. 67, 161\u2013170 (2010).","journal-title":"Arch. Neurol."},{"key":"BFnrneurol201614_CR24","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/S1474-4422(08)70194-7","volume":"7","author":"JC van Swieten","year":"2008","unstructured":"van Swieten, J. C. & Heutink, P. Mutations in progranulin (GRN) within the spectrum of clinical and pathological phenotypes of frontotemporal dementia. Lancet Neurol. 7, 965\u2013974 (2008).","journal-title":"Lancet Neurol."},{"key":"BFnrneurol201614_CR25","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1001\/archneur.65.4.460","volume":"65","author":"BF Boeve","year":"2008","unstructured":"Boeve, B. F. & Hutton, M. Refining frontotemporal dementia with parkinsonism linked to chromosome 17: introducing FTDP-17 (MAPT) and FTDP-17 (PGRN). Arch. Neurol. 65, 460\u2013464 (2008).","journal-title":"Arch. Neurol."},{"key":"BFnrneurol201614_CR26","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1212\/WNL.0b013e3181bf997a","volume":"73","author":"JD Rohrer","year":"2009","unstructured":"Rohrer, J. D.  et al. The heritability and genetics of frontotemporal lobar degeneration. Neurology 73, 1451\u20131456 (2009).","journal-title":"Neurology"},{"key":"BFnrneurol201614_CR27","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1212\/WNL.54.9.1787","volume":"54","author":"K Arima","year":"2000","unstructured":"Arima, K.  et al. Two brothers with frontotemporal dementia and parkinsonism with an N279K mutation of the tau gene. Neurology 54, 1787\u20131795 (2000).","journal-title":"Neurology"},{"key":"BFnrneurol201614_CR28","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1212\/WNL.53.4.864","volume":"53","author":"M Yasuda","year":"1999","unstructured":"Yasuda, M.  et al. A mutation in the microtubule- associated protein tau in pallido\u2013nigro\u2013luysian degeneration. Neurology 53, 864\u2013868 (1999).","journal-title":"Neurology"},{"key":"BFnrneurol201614_CR29","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1093\/brain\/awf069","volume":"125","author":"SM Pickering-Brown","year":"2002","unstructured":"Pickering-Brown, S. M.  et al. Inherited frontotemporal dementia in nine British families associated with intronic mutations in the tau gene. Brain 125, 732\u2013751 (2002).","journal-title":"Brain"},{"key":"BFnrneurol201614_CR30","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1111\/j.1365-2990.2007.00918.x","volume":"34","author":"N Bermingham","year":"2008","unstructured":"Bermingham, N., Cowie, T. F., Paine, M., Storey, E. & McLean, C. Frontotemporal dementia and parkinsonism linked to chromosome 17 in a young Australian patient with the G389R Tau mutation. Neuropathol. Appl. Neurobiol. 34, 366\u2013370 (2008).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"BFnrneurol201614_CR31","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1002\/mds.21970","volume":"23","author":"G Rossi","year":"2008","unstructured":"Rossi, G.  et al. The G389R mutation in the MAPT gene presenting as sporadic corticobasal syndrome. Mov. Disord. 23, 892\u2013895 (2008).","journal-title":"Mov. Disord."},{"key":"BFnrneurol201614_CR32","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1097\/NEN.0000000000000248","volume":"74","author":"P Tacik","year":"2015","unstructured":"Tacik, P.  et al. A novel tau mutation in exon 12, p. Q336H, causes hereditary pick disease. J. Neuropathol. Exp. Neurol. 74, 1042\u20131052 (2015).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"BFnrneurol201614_CR33","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s00401-015-1425-0","volume":"130","author":"P Tacik","year":"2015","unstructured":"Tacik, P.  et al. A novel tau mutation, p. K317N, causes globular glial tauopathy. Acta Neuropathol. 130, 199\u2013214 (2015).","journal-title":"Acta Neuropathol."},{"key":"BFnrneurol201614_CR34","doi-asserted-by":"publisher","first-page":"769","DOI":"10.3233\/JAD-130413","volume":"37","author":"MP Chaunu","year":"2013","unstructured":"Chaunu, M. P.  et al. Juvenile frontotemporal dementia with parkinsonism associated with tau mutation G389R. J. Alzheimers Dis. 37, 769\u2013776 (2013).","journal-title":"J. Alzheimers Dis."},{"key":"BFnrneurol201614_CR35","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s00415-003-1074-4","volume":"250","author":"A Lossos","year":"2003","unstructured":"Lossos, A.  et al. Frontotemporal dementia and parkinsonism with the P301S tau gene mutation in a Jewish family. J. Neurol. 250, 733\u2013740 (2003).","journal-title":"J. Neurol."},{"key":"BFnrneurol201614_CR36","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1002\/1531-8249(199911)46:5<708::AID-ANA5>3.0.CO;2-K","volume":"46","author":"AD Sperfeld","year":"1999","unstructured":"Sperfeld, A. D.  et al. FTDP-17: an early phenotype with parkinsonism and epileptic seizures caused by a novel mutation. Ann. Neurol. 46, 708\u2013715 (1999).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol201614_CR37","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1002\/mds.10401","volume":"18","author":"E Werber","year":"2003","unstructured":"Werber, E., Klein, C., Gr\u00fcnfeld, J. & Rabey, J. M. Phenotypic presentation of frontotemporal dementia with parkinsonism-chromosome 17 type P301S in a patient of Jewish\u2013Algerian origin. Mov. Disord. 18, 595\u2013598 (2003).","journal-title":"Mov. Disord."},{"key":"BFnrneurol201614_CR38","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1093\/brain\/awh356","volume":"128","author":"BF Boeve","year":"2005","unstructured":"Boeve, B. F.  et al. Longitudinal characterization of two siblings with frontotemporal dementia and parkinsonism linked to chromosome 17 associated with the S305N tau mutation. Brain 128, 752\u2013772 (2005).","journal-title":"Brain"},{"key":"BFnrneurol201614_CR39","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/j.1468-1331.2007.02017.x","volume":"15","author":"L Skoglund","year":"2008","unstructured":"Skoglund, L.  et al. The tau S305S mutation causes frontotemporal dementia with parkinsonism. Eur. J. Neurol. 15, 156\u2013161 (2008).","journal-title":"Eur. J. Neurol."},{"key":"BFnrneurol201614_CR40","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1212\/WNL.44.10.1878","volume":"44","author":"T Lynch","year":"1994","unstructured":"Lynch, T.  et al. Clinical characteristics of a family with chromosome 17-linked disinhibition\u2212dementia\u2212parkinsonism\u2212amyotrophy complex. Neurology 44, 1878\u20131884 (1994).","journal-title":"Neurology"},{"key":"BFnrneurol201614_CR41","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1159\/000319454","volume":"8","author":"JD Rohrer","year":"2011","unstructured":"Rohrer, J. D.  et al. Novel L284R MAPT mutation in a family with an autosomal dominant progressive supranuclear palsy syndrome. Neurodegener. Dis. 8, 149\u2013152 (2011).","journal-title":"Neurodegener. Dis."},{"key":"BFnrneurol201614_CR42","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.parkreldis.2012.06.019","volume":"19","author":"K Ogaki","year":"2013","unstructured":"Ogaki, K.  et al. Analyses of the MAPT, PGRN, and C9orf72 mutations in Japanese patients with FTLD, PSP, and CBS. Parkinsonism Relat. Disord. 19, 15\u201320 (2013).","journal-title":"Parkinsonism Relat. Disord."},{"key":"BFnrneurol201614_CR43","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1093\/brain\/awm280","volume":"131","author":"S Spina","year":"2008","unstructured":"Spina, S.  et al. The tauopathy associated with mutation +3 in intron 10 of tau: characterization of the MSTD family. Brain 131, 72\u201389 (2008).","journal-title":"Brain"},{"key":"BFnrneurol201614_CR44","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1007\/s00702-007-0632-9","volume":"114","author":"Y Baba","year":"2007","unstructured":"Baba, Y.  et al. Clinical and genetic features of families with frontotemporal dementia and parkinsonism linked to chromosome 17 with a P301S tau mutation. J. Neural Transm. (Vienna) 114, 947\u2013950 (2007).","journal-title":"J. Neural Transm. (Vienna)"},{"key":"BFnrneurol201614_CR45","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s00401-013-1193-7","volume":"127","author":"N Kouri","year":"2014","unstructured":"Kouri, N.  et al. Novel mutation in MAPT exon 13 (p.N410H) causes corticobasal degeneration. Acta Neuropathol. 127, 271\u2013282 (2014).","journal-title":"Acta Neuropathol."},{"key":"BFnrneurol201614_CR46","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.neurobiolaging.2007.08.022","volume":"30","author":"BJ Kelly","year":"2009","unstructured":"Kelly, B. J.  et al. Prominent phenotypic variability associated with mutations in progranulin. Neurobiol. Aging 30, 739\u2013751 (2009).","journal-title":"Neurobiol. Aging"},{"key":"BFnrneurol201614_CR47","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1093\/brain\/awn012","volume":"131","author":"I Le Ber","year":"2008","unstructured":"Le Ber, I.  et al. Phenotype variability in progranulin mutation carriers: a clinical, neuropsychological, imaging and genetic study. Brain 131, 732\u2013746 (2008).","journal-title":"Brain"},{"key":"BFnrneurol201614_CR48","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1212\/01.wnl.0000267701.58488.69","volume":"69","author":"S Davion","year":"2007","unstructured":"Davion, S.  et al. Clinicopathologic correlation in PGRN mutations. Neurology 69, 1113\u20131121 (2007).","journal-title":"Neurology"},{"key":"BFnrneurol201614_CR49","doi-asserted-by":"publisher","first-page":"3115","DOI":"10.1093\/brain\/awl276","volume":"129","author":"M Masellis","year":"2006","unstructured":"Masellis, M.  et al. Novel splicing mutation in the progranulin gene causing familial corticobasal syndrome. Brain 129, 3115\u20133123 (2006).","journal-title":"Brain"},{"key":"BFnrneurol201614_CR50","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1097\/nen.0b013e31803020cf","volume":"66","author":"KA Josephs","year":"2007","unstructured":"Josephs, K. A.  et al. Neuropathologic features of frontotemporal lobar degeneration with ubiquitin-positive inclusions with progranulin gene (PGRN) mutations. J. Neuropathol. Exp. Neurol. 66, 142\u2013151 (2007).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"BFnrneurol201614_CR51","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1097\/nen.0b013e3181567873","volume":"66","author":"S Spina","year":"2007","unstructured":"Spina, S.  et al. Corticobasal syndrome associated with the A9D progranulin mutation. J. Neuropathol. Exp. Neurol. 66, 892\u2013900 (2007).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"BFnrneurol201614_CR52","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.neurobiolaging.2006.10.028","volume":"29","author":"L Benussi","year":"2008","unstructured":"Benussi, L.  et al. A novel deletion in progranulin gene is associated with FTDP-17 and CBS. Neurobiol. Aging 29, 427\u2013435 (2008).","journal-title":"Neurobiol. Aging"},{"key":"BFnrneurol201614_CR53","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.nbd.2008.11.008","volume":"33","author":"L Benussi","year":"2009","unstructured":"Benussi, L.  et al. Progranulin Leu271LeufsX10 is one of the most common FTLD and CBS associated mutations worldwide. Neurobiol. Dis. 33, 379\u2013385 (2009).","journal-title":"Neurobiol. Dis."},{"key":"BFnrneurol201614_CR54","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1471-2377-11-50","volume":"11","author":"R Rusina","year":"2011","unstructured":"Rusina, R.  et al. FTLD-TDP with motor neuron disease, visuospatial impairment and a progressive supranuclear palsy-like syndrome: broadening the clinical phenotype of TDP-43 proteinopathies. A report of three cases. BMC Neurol. 11, 50 (2011).","journal-title":"BMC Neurol."},{"key":"BFnrneurol201614_CR55","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.neuron.2011.09.010","volume":"72","author":"AE Renton","year":"2011","unstructured":"Renton, A. E.  et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72, 257\u2013268 (2011).","journal-title":"Neuron"},{"key":"BFnrneurol201614_CR56","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1136\/jnnp-2011-301883","volume":"83","author":"BK Khan","year":"2012","unstructured":"Khan, B. K.  et al. Atypical, slowly progressive behavioural variant frontotemporal dementia associated with C9ORF72 hexanucleotide expansion. J. Neurol. Neurosurg. Psychiatry 83, 358\u2013364 (2012).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BFnrneurol201614_CR57","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1001\/2013.jamaneurol.181","volume":"70","author":"T Van Langenhove","year":"2013","unstructured":"Van Langenhove, T.  et al. Distinct clinical characteristics of C9orf72 expansion carriers compared with GRN, MAPT, and nonmutation carriers in a Flanders\u2013Belgian FTLD cohort. JAMA Neurol. 70, 365\u2013373 (2013).","journal-title":"JAMA Neurol."},{"key":"BFnrneurol201614_CR58","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1093\/brain\/aws004","volume":"135","author":"BF Boeve","year":"2012","unstructured":"Boeve, B. F.  et al. Characterization of frontotemporal dementia and\/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72. Brain 135, 765\u2013783 (2012).","journal-title":"Brain"},{"key":"BFnrneurol201614_CR59","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1002\/mds.25022","volume":"27","author":"S O'Dowd","year":"2012","unstructured":"O'Dowd, S.  et al. C9ORF72 expansion in amyotrophic lateral sclerosis\/frontotemporal dementia also causes parkinsonism. Mov. Disord. 27, 1072\u20131074 (2012).","journal-title":"Mov. Disord."},{"key":"BFnrneurol201614_CR60","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1001\/jamaneurol.2013.5762","volume":"71","author":"JS Goldman","year":"2014","unstructured":"Goldman, J. S.  et al. Multiple system atrophy and amyotrophic lateral sclerosis in a family with hexanucleotide repeat expansions in C9orf72. JAMA Neurol. 71, 771\u2013774 (2014).","journal-title":"JAMA Neurol."},{"key":"BFnrneurol201614_CR61","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1212\/WNL.0b013e3182a2cc38","volume":"81","author":"J Cooper-Knock","year":"2013","unstructured":"Cooper-Knock, J.  et al. C9ORF72 expansions, parkinsonism, and Parkinson disease: a clinicopathologic study. Neurology 81, 808\u2013811 (2013).","journal-title":"Neurology"},{"key":"BFnrneurol201614_CR62","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/j.1399-0004.2012.01903.x","volume":"83","author":"SG Lindquist","year":"2013","unstructured":"Lindquist, S. G.  et al. Corticobasal and ataxia syndromes widen the spectrum of C9ORF72 hexanucleotide expansion disease. Clin. Genet. 83, 279\u2013283 (2013).","journal-title":"Clin. Genet."},{"key":"BFnrneurol201614_CR63","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1093\/brain\/awr355","volume":"135","author":"JS Snowden","year":"2012","unstructured":"Snowden, J. S.  et al. Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations. Brain 135, 693\u2013708 (2012).","journal-title":"Brain"},{"key":"BFnrneurol201614_CR64","doi-asserted-by":"publisher","first-page":"1710.e7","DOI":"10.1016\/j.neurobiolaging.2012.11.025","volume":"34","author":"H Daoud","year":"2013","unstructured":"Daoud, H.  et al. Investigation of C9orf72 repeat expansions in Parkinson's disease. Neurobiol. Aging 34, 1710.e7\u20131710.e9 (2013).","journal-title":"Neurobiol. Aging"},{"key":"BFnrneurol201614_CR65","doi-asserted-by":"publisher","first-page":"1519.e1","DOI":"10.1016\/j.neurobiolaging.2012.10.001","volume":"34","author":"MB Harms","year":"2013","unstructured":"Harms, M. B.  et al. Parkinson disease is not associated with C9ORF72 repeat expansions. Neurobiol. Aging 34, 1519.e1\u20131519.e2 (2013).","journal-title":"Neurobiol. Aging"},{"key":"BFnrneurol201614_CR66","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1001\/archneurol.2012.2016","volume":"69","author":"Z Xi","year":"2012","unstructured":"Xi, Z.  et al. Investigation of c9orf72 in 4 neurodegenerative disorders. Arch. Neurol. 69, 1583\u20131590 (2012).","journal-title":"Arch. Neurol."},{"key":"BFnrneurol201614_CR67","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1093\/brain\/aws357","volume":"136","author":"S Lesage","year":"2013","unstructured":"Lesage, S.  et al. C9orf72 repeat expansions are a rare genetic cause of parkinsonism. Brain 136, 385\u2013391 (2013).","journal-title":"Brain"},{"key":"BFnrneurol201614_CR68","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S1474-4422(12)70043-1","volume":"11","author":"E Majounie","year":"2012","unstructured":"Majounie, E.  et al. Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurol. 11, 323\u2013330 (2012).","journal-title":"Lancet Neurol."},{"key":"BFnrneurol201614_CR69","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/ahg.12033","volume":"77","author":"K Nuytemans","year":"2013","unstructured":"Nuytemans, K.  et al. C9ORF72 intermediate repeat copies are a significant risk factor for Parkinson disease. Ann. Hum. Genet. 77, 351\u2013363 (2013).","journal-title":"Ann. Hum. Genet."},{"key":"BFnrneurol201614_CR70","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3109\/17482968.2012.725415","volume":"14","author":"C Akimoto","year":"2013","unstructured":"Akimoto, C.  et al. No GGGGCC-hexanucleotide repeat expansion in C9ORF72 in parkinsonism patients in Sweden. Amyotroph. Lateral Scler. Frontotemporal Degener. 14, 26\u201329 (2013).","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener."},{"key":"BFnrneurol201614_CR71","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s00401-014-1251-9","volume":"127","author":"J Cooper-Knock","year":"2014","unstructured":"Cooper-Knock, J., Shaw, P. J. & Kirby, J. The widening spectrum of C9ORF72-related disease; genotype\/phenotype correlations and potential modifiers of clinical phenotype. Acta Neuropathol. 127, 333\u2013345 (2014).","journal-title":"Acta Neuropathol."},{"key":"BFnrneurol201614_CR72","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1001\/jamaneurol.2013.1817","volume":"70","author":"BA Dombroski","year":"2013","unstructured":"Dombroski, B. A.  et al. C9orf72 hexanucleotide repeat expansion and Guam amyotrophic lateral sclerosis-parkinsonism-dementia complex. JAMA Neurol. 70, 742\u2013745 (2013).","journal-title":"JAMA Neurol."},{"key":"BFnrneurol201614_CR73","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1007\/s00415-012-6444-3","volume":"259","author":"G Floris","year":"2012","unstructured":"Floris, G.  et al. Frontotemporal dementia with psychosis, parkinsonism, visuo-spatial dysfunction, upper motor neuron involvement associated to expansion of C9ORF72: a peculiar phenotype? J. Neurol. 259, 1749\u20131751 (2012).","journal-title":"J. Neurol."},{"key":"BFnrneurol201614_CR74","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1136\/jnnp-2012-303032","volume":"83","author":"JS Snowden","year":"2012","unstructured":"Snowden, J. S.  et al. Psychosis, C9ORF72 and dementia with Lewy bodies. J. Neurol. Neurosurg. Psychiatry 83, 1031\u20131032 (2012).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BFnrneurol201614_CR75","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1136\/jnnp-2014-307622","volume":"85","author":"A Robinson","year":"2014","unstructured":"Robinson, A., Davidson, Y., Snowden, J. S. & Mann, D. M. C9ORF72 in dementia with Lewy bodies. J. Neurol. Neurosurg. Psychiatry 85, 1435\u20131436 (2014).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BFnrneurol201614_CR76","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1136\/jnnp-2012-302577","volume":"83","author":"S Morgan","year":"2012","unstructured":"Morgan, S.  et al. Differentiation of frontotemporal dementia from dementia with Lewy bodies using FP-CIT SPECT. J. Neurol. Neurosurg. Psychiatry 83, 1063\u20131070 (2012).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BFnrneurol201614_CR77","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.neuron.2010.11.036","volume":"68","author":"JO Johnson","year":"2010","unstructured":"Johnson, J. O.  et al. Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron 68, 857\u2013864 (2010).","journal-title":"Neuron"},{"key":"BFnrneurol201614_CR78","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/j.1468-1331.2012.03831.x","volume":"20","author":"S Spina","year":"2013","unstructured":"Spina, S.  et al. Phenotypic variability in three families with valosin-containing protein mutation. Eur. J. Neurol. 20, 251\u2013258 (2013).","journal-title":"Eur. J. Neurol."},{"key":"BFnrneurol201614_CR79","doi-asserted-by":"publisher","first-page":"209.e1","DOI":"10.1016\/j.neurobiolaging.2011.07.011","volume":"33","author":"E Majounie","year":"2012","unstructured":"Majounie, E.  et al. Mutational analysis of the VCP gene in Parkinson's disease. Neurobiol. Aging 33, 209.e1\u2013209.e2 (2012).","journal-title":"Neurobiol. Aging"},{"key":"BFnrneurol201614_CR80","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1212\/01.WNL.0000034763.54161.1F","volume":"59","author":"S Gydesen","year":"2002","unstructured":"Gydesen, S.  et al. Chromosome 3 linked frontotemporal dementia (FTD-3). Neurology 59, 1585\u20131594 (2002).","journal-title":"Neurology"},{"key":"BFnrneurol201614_CR81","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nrneurol.2014.78","volume":"10","author":"H Deng","year":"2014","unstructured":"Deng, H., Gao, K. & Jankovic, J. The role of FUS gene variants in neurodegenerative diseases. Nat. Rev. Neurol. 10, 337\u2013348 (2014).","journal-title":"Nat. Rev. Neurol."},{"key":"BFnrneurol201614_CR82","doi-asserted-by":"publisher","first-page":"246","DOI":"10.2174\/156720511795563764","volume":"8","author":"AM Isaacs","year":"2011","unstructured":"Isaacs, A. M., Johannsen, P., Holm, I. & Nielsen, J. E. & FReJA consortium. Frontotemporal dementia caused by CHMP2B mutations. Curr. Alzheimer Res. 8, 246\u2013251 (2011).","journal-title":"Curr. Alzheimer Res."},{"key":"BFnrneurol201614_CR83","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1212\/WNL.0b013e3181f07e0c","volume":"75","author":"J Yan","year":"2010","unstructured":"Yan, J.  et al. Frameshift and novel mutations in FUS in familial amyotrophic lateral sclerosis and ALS\/dementia. Neurology 75, 807\u2013814 (2010).","journal-title":"Neurology"},{"key":"BFnrneurol201614_CR84","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s00415-009-5404-z","volume":"257","author":"H Seelaar","year":"2010","unstructured":"Seelaar, H.  et al. Frequency of ubiquitin and FUS-positive, TDP-43-negative frontotemporal lobar degeneration. J. Neurol. 257, 747\u2013753 (2010).","journal-title":"J. Neurol."},{"key":"BFnrneurol201614_CR85","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1111\/j.1468-1331.2010.02975.x","volume":"17","author":"KA Josephs","year":"2010","unstructured":"Josephs, K. A.  et al. Caudate atrophy on MRI is a characteristic feature of FTLD-FUS. Eur. J. Neurol. 17, 969\u2013975 (2010).","journal-title":"Eur. J. Neurol."},{"key":"BFnrneurol201614_CR86","doi-asserted-by":"publisher","first-page":"1846.e1","DOI":"10.1016\/j.neurobiolaging.2012.01.108","volume":"33","author":"L Mosca","year":"2012","unstructured":"Mosca, L.  et al. Wide phenotypic spectrum of the TARDBP gene: homozygosity of A382T mutation in a patient presenting with amyotrophic lateral sclerosis, Parkinson's disease, and frontotemporal lobar degeneration, and in neurologically healthy subject. Neurobiol. Aging 33, 1846.e1\u20131846.e4 (2012).","journal-title":"Neurobiol. Aging"},{"key":"BFnrneurol201614_CR87","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s10048-011-0288-3","volume":"12","author":"M Quadri","year":"2011","unstructured":"Quadri, M.  et al. Broadening the phenotype of TARDBP mutations: the TARDBP Ala382Thr mutation and Parkinson's disease in Sardinia. Neurogenetics 12, 203\u2013209 (2011).","journal-title":"Neurogenetics"},{"key":"BFnrneurol201614_CR88","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.parkreldis.2012.11.003","volume":"19","author":"S Rayaprolu","year":"2013","unstructured":"Rayaprolu, S.  et al. TARDBP mutations in Parkinson's disease. Parkinsonism Relat. Disord. 19, 312\u2013315 (2013).","journal-title":"Parkinsonism Relat. Disord."},{"key":"BFnrneurol201614_CR89","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1212\/WNL.0b013e318232ab87","volume":"77","author":"Y Fujita","year":"2011","unstructured":"Fujita, Y., Ikeda, M., Yanagisawa, T., Senoo, Y. & Okamoto, K. Different clinical and neuropathologic phenotypes of familial ALS with A315E TARDBP mutation. Neurology 77, 1427\u20131431 (2011).","journal-title":"Neurology"},{"key":"BFnrneurol201614_CR90","doi-asserted-by":"publisher","first-page":"2327.e1","DOI":"10.1016\/j.neurobiolaging.2011.06.009","volume":"32","author":"G Borghero","year":"2011","unstructured":"Borghero, G.  et al. A patient carrying a homozygous p.A382T TARDBP missense mutation shows a syndrome including ALS, extrapyramidal symptoms, and FTD. Neurobiol. Aging 32, 2327.e1\u20132327.e5 (2011).","journal-title":"Neurobiol. Aging"},{"key":"BFnrneurol201614_CR91","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1136\/jnnp.2009.201608","volume":"82","author":"AJ Espay","year":"2011","unstructured":"Espay, A. J.  et al. Rapidly progressive atypical parkinsonism associated with frontotemporal lobar degeneration and motor neuron disease. J. Neurol. Neurosurg. Psychiatry 82, 751\u2013753 (2011).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BFnrneurol201614_CR92","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1001\/archneurol.2008.568","volume":"66","author":"E Kabashi","year":"2009","unstructured":"Kabashi, E.  et al. No TARDBP mutations in a French Canadian population of patients with Parkinson disease. Arch. Neurol. 66, 281\u2013282 (2009).","journal-title":"Arch. Neurol."},{"key":"BFnrneurol201614_CR93","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1016\/j.neurobiolaging.2009.11.018","volume":"32","author":"N Ticozzi","year":"2011","unstructured":"Ticozzi, N.  et al. Mutational analysis of TARDBP in neurodegenerative diseases. Neurobiol. Aging 32, 2096\u20132099 (2011).","journal-title":"Neurobiol. Aging"},{"key":"BFnrneurol201614_CR94","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1084\/jem.20041611","volume":"201","author":"K Takahashi","year":"2005","unstructured":"Takahashi, K., Rochford, C. D. & Neumann, H. Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2. J. Exp. Med. 201, 647\u2013657 (2005).","journal-title":"J. Exp. Med."},{"key":"BFnrneurol201614_CR95","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1023\/B:CEMN.0000012721.08168.ee","volume":"24","author":"MM Bianchin","year":"2004","unstructured":"Bianchin, M. M.  et al. Nasu\u2013Hakola disease (polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy \u2014 PLOSL): a dementia associated with bone cystic lesions. From clinical to genetic and molecular aspects. Cell. Mol. Neurobiol. 24, 1\u201324 (2004).","journal-title":"Cell. Mol. Neurobiol."},{"key":"BFnrneurol201614_CR96","doi-asserted-by":"publisher","first-page":"2077.e11","DOI":"10.1016\/j.neurobiolaging.2013.02.016","volume":"34","author":"M Giraldo","year":"2013","unstructured":"Giraldo, M.  et al. Variants in triggering receptor expressed on myeloid cells 2 are associated with both behavioral variant frontotemporal lobar degeneration and Alzheimer's disease. Neurobiol. Aging 34, 2077.e11\u20132077.e18 (2013).","journal-title":"Neurobiol. Aging"},{"key":"BFnrneurol201614_CR97","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa1211851","volume":"368","author":"R Guerreiro","year":"2013","unstructured":"Guerreiro, R.  et al. TREM2 variants in Alzheimer's disease. N. Engl. J. Med. 368, 117\u2013127 (2013).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneurol201614_CR98","doi-asserted-by":"publisher","first-page":"2419.e23","DOI":"10.1016\/j.neurobiolaging.2014.04.010","volume":"35","author":"I Le Ber","year":"2014","unstructured":"Le Ber, I.  et al. Homozygous TREM2 mutation in a family with atypical frontotemporal dementia. Neurobiol. Aging 35, 2419.e23\u20132419.e25 (2014).","journal-title":"Neurobiol. Aging"},{"key":"BFnrneurol201614_CR99","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1001\/jamaneurol.2013.579","volume":"70","author":"RJ Guerreiro","year":"2013","unstructured":"Guerreiro, R. J.  et al. Using exome sequencing to reveal mutations in TREM2 presenting as a frontotemporal dementia-like syndrome without bone involvement. JAMA Neurol. 70, 78\u201384 (2013).","journal-title":"JAMA Neurol."},{"key":"BFnrneurol201614_CR100","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1750-1326-8-19","volume":"8","author":"S Rayaprolu","year":"2013","unstructured":"Rayaprolu, S.  et al. TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson's disease. Mol. Neurodegener. 8, 19 (2013).","journal-title":"Mol. Neurodegener."},{"key":"BFnrneurol201614_CR101","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1016\/S0002-9440(10)63773-X","volume":"164","author":"NJ Cairns","year":"2004","unstructured":"Cairns, N. J.  et al. \u03b1-internexin is present in the pathological inclusions of neuronal intermediate filament inclusion disease. Am. J. Pathol. 164, 2153\u20132161 (2004).","journal-title":"Am. J. Pathol."},{"key":"BFnrneurol201614_CR102","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1212\/01.WNL.0000139809.16817.DD","volume":"63","author":"NJ Cairns","year":"2004","unstructured":"Cairns, N. J.  et al. Clinical and neuropathologic variation in neuronal intermediate filament inclusion disease. Neurology 63, 1376\u20131384 (2004).","journal-title":"Neurology"},{"key":"BFnrneurol201614_CR103","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1001\/archneurol.2007.37","volume":"65","author":"L Molina-Porcel","year":"2008","unstructured":"Molina-Porcel, L.  et al. Clinical and pathological heterogeneity of neuronal intermediate filament inclusion disease. Arch. Neurol. 65, 272\u2013275 (2008).","journal-title":"Arch. Neurol."},{"key":"BFnrneurol201614_CR104","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1093\/brain\/awu067","volume":"137","author":"TH Wong","year":"2014","unstructured":"Wong, T. H.  et al. PRKAR1B mutation associated with a new neurodegenerative disorder with unique pathology. Brain 137, 1361\u20131373 (2014).","journal-title":"Brain"},{"key":"BFnrneurol201614_CR105","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1017\/S1092852900028443","volume":"13","author":"MF Mendez","year":"2008","unstructured":"Mendez, M. F. & Shapira, J. S. The spectrum of recurrent thoughts and behaviors in frontotemporal dementia. CNS Spectr. 13, 202\u2013208 (2008).","journal-title":"CNS Spectr."},{"key":"BFnrneurol201614_CR106","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0165-1781(02)00094-X","volume":"110","author":"K Shigenobu","year":"2002","unstructured":"Shigenobu, K.  et al. The Stereotypy Rating Inventory for frontotemporal lobar degeneration. Psychiatry Res. 110, 175\u2013187 (2002).","journal-title":"Psychiatry Res."},{"key":"BFnrneurol201614_CR107","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1002\/mds.22555","volume":"24","author":"FJ Mateen","year":"2009","unstructured":"Mateen, F. J. & Josephs, K. A. The clinical spectrum of stereotypies in frontotemporal lobar degeneration. Mov. Disord. 24, 1237\u20131240 (2009).","journal-title":"Mov. Disord."},{"key":"BFnrneurol201614_CR108","first-page":"380","volume-title":"Principles and Practice of Movement Disorders","author":"J Jankovic","year":"2011","unstructured":"Jankovic, J. in Principles and Practice of Movement Disorders 2nd edn Ch. 17 (eds Fahn, S., Jankovic, J. & Hallett, M.) 380\u2013388 (Churchill Linvingstone, 2011)."},{"key":"BFnrneurol201614_CR109","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1002\/mds.23994","volume":"27","author":"MJ Edwards","year":"2012","unstructured":"Edwards, M. J., Lang, A. E. & Bhatia, K. P. Stereotypies: a critical appraisal and suggestion of a clinically useful definition. Mov. Disord. 27, 179\u2013185 (2012).","journal-title":"Mov. Disord."},{"key":"BFnrneurol201614_CR110","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1176\/jnp.6.2.100","volume":"6","author":"D Ames","year":"1994","unstructured":"Ames, D., Cummings, J. L., Wirshing, W. C., Quinn, B. & Mahler, M. Repetitive and compulsive behavior in frontal lobe degenerations. J. Neuropsychiatry Clin. Neurosci. 6, 100\u2013113 (1994).","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"BFnrneurol201614_CR111","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1007\/s00415-012-6528-0","volume":"259","author":"S Prioni","year":"2012","unstructured":"Prioni, S.  et al. Stereotypic behaviors in degenerative dementias. J. Neurol. 259, 2452\u20132459 (2012).","journal-title":"J. Neurol."},{"key":"BFnrneurol201614_CR112","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1212\/WNL.48.4.937","volume":"48","author":"BL Miller","year":"1997","unstructured":"Miller, B. L.  et al. A study of the Lund\u2013Manchester research criteria for frontotemporal dementia: clinical and single-photon emission CT correlations. Neurology 48, 937\u2013942 (1997).","journal-title":"Neurology"},{"key":"BFnrneurol201614_CR113","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1136\/jnnp.69.2.178","volume":"69","author":"S Bozeat","year":"2000","unstructured":"Bozeat, S., Gregory, C. A., Ralph, M. A. & Hodges, J. R. Which neuropsychiatric and behavioural features distinguish frontal and temporal variants of frontotemporal dementia from Alzheimer's disease? J. Neurol. Neurosurg. Psychiatry 69, 178\u2013186 (2000).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BFnrneurol201614_CR114","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1136\/jnnp.74.10.1398","volume":"74","author":"S Nyatsanza","year":"2003","unstructured":"Nyatsanza, S.  et al. A study of stereotypic behaviours in Alzheimer's disease and frontal and temporal variant frontotemporal dementia. J. Neurol. Neurosurg. Psychiatry 74, 1398\u20131402 (2003).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BFnrneurol201614_CR115","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1136\/jnnp.70.3.323","volume":"70","author":"JS Snowden","year":"2001","unstructured":"Snowden, J. S.  et al. Distinct behavioural profiles in frontotemporal dementia and semantic dementia. J. Neurol. Neurosurg. Psychiatry 70, 323\u2013332 (2001).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BFnrneurol201614_CR116","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1159\/000076343","volume":"17","author":"M Ikeda","year":"2004","unstructured":"Ikeda, M.  et al. Efficacy of fluvoxamine as a treatment for behavioral symptoms in frontotemporal lobar degeneration patients. Dement. Geriatr. Cogn. Disord. 17, 117\u2013121 (2004).","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"BFnrneurol201614_CR117","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1176\/appi.neuropsych.11030077","volume":"24","author":"WG Ondo","year":"2012","unstructured":"Ondo, W. G. Tetrabenazine treatment for stereotypies and tics associated with dementia. J. Neuropsychiatry Clin. Neurosci. 24, 208\u2013214 (2012).","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"BFnrneurol201614_CR118","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1586\/ern.11.149","volume":"11","author":"J Jankovic","year":"2011","unstructured":"Jankovic, J. & Clarence-Smith, K. Tetrabenazine for the treatment of chorea and other hyperkinetic movement disorders. Expert Rev. Neurother. 11, 1509\u20131523 (2011).","journal-title":"Expert Rev. Neurother."},{"key":"BFnrneurol201614_CR119","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1017\/S1041610210000098","volume":"22","author":"TR Nielsen","year":"2010","unstructured":"Nielsen, T. R., Bruhn, P., Nielsen, J. E. & Hjermind, L. E. Behavioral variant of frontotemporal dementia mimicking Huntington's disease. Int. Psychogeriatr. 22, 674\u2013677 (2010).","journal-title":"Int. Psychogeriatr."},{"key":"BFnrneurol201614_CR120","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1002\/mds.22697","volume":"24","author":"GG Kovacs","year":"2009","unstructured":"Kovacs, G. G.  et al. TARDBP variation associated with frontotemporal dementia, supranuclear gaze palsy, and chorea. Mov. Disord. 24, 1843\u20131847 (2009).","journal-title":"Mov. Disord."},{"key":"BFnrneurol201614_CR121","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1002\/mds.22065","volume":"23","author":"C Wider","year":"2008","unstructured":"Wider, C.  et al. Progranulin gene mutation with an unusual clinical and neuropathologic presentation. Mov. Disord. 23, 1168\u20131173 (2008).","journal-title":"Mov. Disord."},{"key":"BFnrneurol201614_CR122","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1212\/WNL.0000000000000061","volume":"82","author":"DJ Hensman Moss","year":"2014","unstructured":"Hensman Moss, D. J.  et al. C9orf72 expansions are the most common genetic cause of Huntington disease phenocopies. Neurology 82, 292\u2013299 (2014).","journal-title":"Neurology"},{"key":"BFnrneurol201614_CR123","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.parkreldis.2012.09.013","volume":"19","author":"M Dejesus-Hernandez","year":"2013","unstructured":"Dejesus-Hernandez, M.  et al. Analysis of the C9orf72 repeat in Parkinson's disease, essential tremor and restless legs syndrome. Parkinsonism Relat. Disord. 19, 198\u2013201 (2013).","journal-title":"Parkinsonism Relat. Disord."},{"key":"BFnrneurol201614_CR124","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S1353-8020(02)00054-8","volume":"9","author":"JN Caviness","year":"2003","unstructured":"Caviness, J. N. Myoclonus and neurodegenerative disease \u2014 what's in a name? Parkinsonism Relat. Disord. 9, 185\u2013192 (2003).","journal-title":"Parkinsonism Relat. Disord."},{"key":"BFnrneurol201614_CR125","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1007\/s00415-002-0759-4","volume":"249","author":"SA Curcio","year":"2002","unstructured":"Curcio, S. A.  et al. A large Calabrian kindred segregating frontotemporal dementia. J. Neurol. 249, 911\u2013922 (2002).","journal-title":"J. Neurol."},{"key":"BFnrneurol201614_CR126","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1212\/01.wnl.0000265220.64396.b4","volume":"69","author":"AC Bruni","year":"2007","unstructured":"Bruni, A. C.  et al. Heterogeneity within a large kindred with frontotemporal dementia: a novel progranulin mutation. Neurology 69, 140\u2013147 (2007).","journal-title":"Neurology"},{"key":"BFnrneurol201614_CR127","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1007\/s00415-013-6942-y","volume":"260","author":"M Pail","year":"2013","unstructured":"Pail, M., Matej, R., Husarova, I. & Rektorova, I. Generalized myoclonus as a prominent symptom in a patient with FTLD-TDP. J. Neurol. 260, 1681\u20131683 (2013).","journal-title":"J. Neurol."},{"key":"BFnrneurol201614_CR128","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1002\/mds.1038","volume":"16","author":"Z Vanek","year":"2001","unstructured":"Vanek, Z. & Jankovic, J. Dystonia in corticobasal degeneration. Mov. Disord. 16, 252\u2013257 (2001).","journal-title":"Mov. Disord."},{"key":"BFnrneurol201614_CR129","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1002\/mds.24992","volume":"27","author":"M Stamelou","year":"2012","unstructured":"Stamelou, M., Alonso-Canovas, A. & Bhatia, K. P. Dystonia in corticobasal degeneration: a review of the literature on 404 pathologically proven cases. Mov. Disord. 27, 696\u2013702 (2012).","journal-title":"Mov. Disord."},{"key":"BFnrneurol201614_CR130","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.ajhg.2012.07.002","volume":"91","author":"ND Merner","year":"2012","unstructured":"Merner, N. D.  et al. Exome sequencing identifies FUS mutations as a cause of essential tremor. Am. J. Hum. Genet. 91, 313\u2013319 (2012).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrneurol201614_CR131","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1001\/jamaneurol.2013.572","volume":"70","author":"H Deng","year":"2013","unstructured":"Deng, H., Liang, H. & Jankovic, J. F-box only protein 7 gene in parkinsonian-pyramidal disease. JAMA Neurol. 70, 20\u201324 (2013).","journal-title":"JAMA Neurol."},{"key":"BFnrneurol201614_CR132","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1002\/mds.26145","volume":"30","author":"F Hopfner","year":"2015","unstructured":"Hopfner, F.  et al. The impact of rare variants in FUS in essential tremor. Mov. Disord. 30, 721\u2013724 (2015).","journal-title":"Mov. Disord."},{"key":"BFnrneurol201614_CR133","first-page":"1875","volume":"39","author":"K Ishii","year":"1998","unstructured":"Ishii, K.  et al. Cerebral glucose metabolism in patients with frontotemporal dementia. J. Nucl. Med. 39, 1875\u20131878 (1998).","journal-title":"J. Nucl. Med."},{"key":"BFnrneurol201614_CR134","first-page":"233","volume":"46","author":"Y Jeong","year":"2005","unstructured":"Jeong, Y.  et al. 18F-FDG PET findings in frontotemporal dementia: an SPM analysis of 29 patients. J. Nucl. Med. 46, 233\u2013239 (2005).","journal-title":"J. Nucl. Med."},{"key":"BFnrneurol201614_CR135","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.neurobiolaging.2005.11.002","volume":"28","author":"J Diehl-Schmid","year":"2007","unstructured":"Diehl-Schmid, J.  et al. Decline of cerebral glucose metabolism in frontotemporal dementia: a longitudinal 18F-FDG-PET-study. Neurobiol. Aging 28, 42\u201350 (2007).","journal-title":"Neurobiol. Aging"},{"key":"BFnrneurol201614_CR136","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.neurobiolaging.2009.05.004","volume":"32","author":"V Garibotto","year":"2011","unstructured":"Garibotto, V.  et al. Subcortical and deep cortical atrophy in frontotemporal lobar degeneration. Neurobiol. Aging 32, 875\u2013884 (2011).","journal-title":"Neurobiol. Aging"},{"key":"BFnrneurol201614_CR137","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.3174\/ajnr.A1168","volume":"29","author":"JC Looi","year":"2008","unstructured":"Looi, J. C.  et al. Caudate nucleus volumes in frontotemporal lobar degeneration: differential atrophy in subtypes. AJNR Am. J. Neuroradiol. 29, 1537\u20131543 (2008).","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"BFnrneurol201614_CR138","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.3174\/ajnr.A1640","volume":"30","author":"JC Looi","year":"2009","unstructured":"Looi, J. C.  et al. Putaminal volume in frontotemporal lobar degeneration and Alzheimer disease: differential volumes in dementia subtypes and controls. AJNR Am. J. Neuroradiol. 30, 1552\u20131560 (2009).","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"BFnrneurol201614_CR139","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1097\/WAD.0b013e31824a7df4","volume":"27","author":"C Halabi","year":"2013","unstructured":"Halabi, C.  et al. Patterns of striatal degeneration in frontotemporal dementia. Alzheimer Dis. Assoc. Disord. 27, 74\u201383 (2013).","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"BFnrneurol201614_CR140","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1212\/WNL.58.10.1489","volume":"58","author":"JO Rinne","year":"2002","unstructured":"Rinne, J. O.  et al. Striatal dopamine transporter and extrapyramidal symptoms in frontotemporal dementia. Neurology 58, 1489\u20131493 (2002).","journal-title":"Neurology"},{"key":"BFnrneurol201614_CR141","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1159\/000105159","volume":"4","author":"F Sedaghat","year":"2007","unstructured":"Sedaghat, F.  et al. Evaluation of dopaminergic function in frontotemporal dementia using I-FP-CIT single photon emission computed tomography. Neurodegener. Dis. 4, 382\u2013385 (2007).","journal-title":"Neurodegener. Dis."},{"key":"BFnrneurol201614_CR142","doi-asserted-by":"publisher","first-page":"747","DOI":"10.3233\/JAD-131151","volume":"38","author":"M Carecchio","year":"2014","unstructured":"Carecchio, M.  et al. Evidence of pre-synaptic dopaminergic deficit in a patient with a novel progranulin mutation presenting with atypical parkinsonism. J. Alzheimers Dis. 38, 747\u2013752 (2014).","journal-title":"J. Alzheimers Dis."},{"key":"BFnrneurol201614_CR143","doi-asserted-by":"publisher","first-page":"15997","DOI":"10.1073\/pnas.0808084105","volume":"105","author":"LM Ittner","year":"2008","unstructured":"Ittner, L. M.  et al. Parkinsonism and impaired axonal transport in a mouse model of frontotemporal dementia. Proc. Natl Acad. Sci. USA 105, 15997\u201316002 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneurol201614_CR144","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S1353-8020(00)00026-2","volume":"7","author":"PK Pal","year":"2001","unstructured":"Pal, P. K.  et al. Positron emission tomography in pallido\u2013ponto\u2013nigral degeneration (PPND) family (frontotemporal dementia with parkinsonism linked to chromosome 17 and point mutation in tau gene). Parkinsonism Relat. Disord. 7, 81\u201388 (2001).","journal-title":"Parkinsonism Relat. Disord."},{"key":"BFnrneurol201614_CR145","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1523\/JNEUROSCI.05-03-00776.1985","volume":"5","author":"LD Selemon","year":"1985","unstructured":"Selemon, L. D. & Goldman-Rakic, P. S. Longitudinal topography and interdigitation of corticostriatal projections in the rhesus monkey. J. Neurosci. 5, 776\u2013794 (1985).","journal-title":"J. Neurosci."},{"key":"BFnrneurol201614_CR146","first-page":"240","volume":"18","author":"K Kobayashi","year":"1999","unstructured":"Kobayashi, K.  et al. KP1 expression of ghost Pick bodies, amyloid P-positive astrocytes and selective nigral degeneration in early onset Picks disease. Clin. Neuropathol. 18, 240\u2013249 (1999).","journal-title":"Clin. Neuropathol."},{"key":"BFnrneurol201614_CR147","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1212\/01.wnl.0000277461.06713.23","volume":"69","author":"JD Woolley","year":"2007","unstructured":"Woolley, J. D.  et al. Binge eating is associated with right orbitofrontal-insular-striatal atrophy in frontotemporal dementia. Neurology 69, 1424\u20131433 (2007).","journal-title":"Neurology"},{"key":"BFnrneurol201614_CR148","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1016\/j.neurobiolaging.2007.04.027","volume":"29","author":"KA Josephs","year":"2008","unstructured":"Josephs, K. A., Whitwell, J. L. & Jack, C. R. Jr. Anatomic correlates of stereotypies in frontotemporal lobar degeneration. Neurobiol. Aging. 29, 1859\u20131863 (2008).","journal-title":"Neurobiol. Aging."},{"key":"BFnrneurol201614_CR149","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s11910-014-0489-x","volume":"14","author":"J Diehl-Schmid","year":"2014","unstructured":"Diehl-Schmid, J., Onur, O. A., Kuhn, J., Gruppe, T. & Drzezga, A. Imaging frontotemporal lobar degeneration. Curr. Neurol. Neurosci. Rep. 14, 489 (2014).","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"BFnrneurol201614_CR150","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1111\/ene.12211","volume":"20","author":"E G\u00f3mez-Tortosa","year":"2013","unstructured":"G\u00f3mez-Tortosa, E.  et al. Plasma progranulin levels in cortical dementia phenotypes with asymmetric perisylvian atrophy. Eur. J. Neurol. 20, 1319\u20131324 (2013).","journal-title":"Eur. J. Neurol."},{"key":"BFnrneurol201614_CR151","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1093\/brain\/awn352","volume":"132","author":"N Finch","year":"2009","unstructured":"Finch, N.  et al. Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members. Brain 132, 583\u2013591 (2009).","journal-title":"Brain"},{"key":"BFnrneurol201614_CR152","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.neurol.2013.07.014","volume":"169","author":"I Le Ber","year":"2013","unstructured":"Le Ber, I. Genetics of frontotemporal lobar degeneration: an up-date and diagnosis algorithm. Rev. Neurol. (Paris) 169, 811\u2013819 (2013).","journal-title":"Rev. Neurol. (Paris)"},{"key":"BFnrneurol201614_CR153","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1159\/000381828","volume":"40","author":"N Rostgaard","year":"2015","unstructured":"Rostgaard, N., Waldemar, G., Nielsen, J. E. & Simonsen, A. H. Cerebrospinal fluid biomarkers in familial forms of Alzheimer's disease and frontotemporal dementia. Dement. Geriatr. Cogn. Disord. 40, 54\u201362 (2015).","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"BFnrneurol201614_CR154","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.parkreldis.2013.06.016","volume":"19","author":"R Fekete","year":"2013","unstructured":"Fekete, R.  et al. Exome sequencing in familial corticobasal degeneration. Parkinsonism Relat. Disord. 19, 1049\u20131052 (2013).","journal-title":"Parkinsonism Relat. Disord."},{"key":"BFnrneurol201614_CR155","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1016\/j.parkreldis.2015.08.011","volume":"22","author":"M Dani","year":"2016","unstructured":"Dani, M. Edison, P. & Brooks, D. J. Imaging biomarkers in tauopathies. Parkinsonism Relat. Disord. 22, S26\u2013S28 (2016).","journal-title":"Parkinsonism Relat. Disord."},{"key":"BFnrneurol201614_CR156","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12974-015-0236-5","volume":"12","author":"J Zhang","year":"2015","unstructured":"Zhang, J. Mapping neuroinflammation in frontotemporal dementia with molecular PET imaging. J. Neuroinflamm. 12, 108 (2015).","journal-title":"J. Neuroinflamm."},{"key":"BFnrneurol201614_CR157","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1016\/S0140-6736(15)00461-4","volume":"386","author":"J Bang","year":"2015","unstructured":"Bang, J., Spina, S. & Miller, B. L. Frontotemporal dementia. Lancet 386, 1672\u20131682 (2015).","journal-title":"Lancet"}],"container-title":["Nature Reviews Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrneurol.2016.14.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneurol.2016.14","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneurol.2016.14.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:18:32Z","timestamp":1684469912000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrneurol.2016.14"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,19]]},"references-count":157,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["BFnrneurol201614"],"URL":"https:\/\/doi.org\/10.1038\/nrneurol.2016.14","relation":{},"ISSN":["1759-4758","1759-4766"],"issn-type":[{"value":"1759-4758","type":"print"},{"value":"1759-4766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,19]]},"assertion":[{"value":"19 February 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}